In an April 18 article published in Bloomberg BNA’s Pharmaceutical Law & Industry Report, intellectual property litigation partner Peter Brody (Washington, D.C.) discusses the overlap between the Lanham Act and the Federal Food, Drug, and Cosmetic Act. The article, titled “Preclusion, Primary Jurisdiction, and Private Enforcement: The Intersection of the Lanham Act and the Federal Food, Drug, and Cosmetic Act,” provides a framework for greater consistency in the litigation and adjudication of false advertising cases that fall between these statutes.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.